Ulcerative Colitis by Kinietz, Randy
Otterbein University 
Digital Commons @ Otterbein 




Otterbein University, kinietz1@otterbein.edu 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Nursing Commons 
Recommended Citation 
Kinietz, Randy, "Ulcerative Colitis" (2021). Nursing Student Class Projects (Formerly MSN). 467. 
https://digitalcommons.otterbein.edu/stu_msn/467 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Topic 
Ulcerative Colitis (UC) 
Chronic inflammatory disease of
the large intestine, believed to be
of autoimmune origin (Rubin et
al., 2019) 
Prevalence 
• More than one million 
people affected each year in
the United States and 
Europe (Rubin et al., 2019) 
• About 156 to 291 cases per
100,000	 people each year in
the United States (Ungaro et	
al., 2019) 
• Main onset ages 15 to 30
years old (Ungaro et al.,
2019) 
Signs & Symptoms 
• Bloody 	diarrhea 	with 	or 
without mucus	 (Kayal &
Shah, 2020) 
• Tenesmus (Lynch & Hsu,
2021) 
• Abdominal pain (McCance &
Huether, 2018) 
• Malaise (McCance &
Huether, 2018) 
• Weight loss (McCance &
Huether, 2018) 











play a role in its
pathogenesis”	 (Kaur & 
Goggolidou, 2020) 
• Inflammation	 of the 
mucosum	 and sub 
mucosal layer of the	
colon and rectum	 (Kaur 
& Goggolidou, 2020) 









signaling (Kaur & 
Goggolidou, 2020) 
• These loci and the flora 
of the lamina propria 
have been found to 
trigger an overactive 
immune response in 
those that are 
susceptible, causing 
intestinal damage and 
inflammation (Kaur & 
Goggolidou, 2020) 
Risk Factors 
• Age (15-30)	 (Ungaro et
al., 2019) 
• Caucasian (Bye et al., 
2017) 




history (Lynch & Hsu,
2021) 





• Monitor for adverse 





(Lynch & Hsu, 2021) 
• Thorough discharge
instructions on new 




(Lynch & Hsu, 2021) 
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Management 
• First line treatment of UC 
includes sulfasalazine and	 
5-aminosalicylates with
the addition of oral or 
rectal glucocorticoids for	 
those that	 do not	 
experience	 remission
within two to three weeks	 
(Tripathi & Feuerstein,
2019) 





agents such as infliximab
may	 be	 needed to control
inflammation and reduce 
symptomology (Tripathi &
Feuerstein, 2019) 
• Partial or total colectomy
may be needed on a case-
to-case-basis (Gallo et al., 
2018) 
• Considerations for 
surgical management
include (Gallo et al., 2018): 
• Failure of 
medical therapy 
• Strictures 
• Perforation 
• Toxic 
megacolon 
• Uncontrollable 
bleeding 
• Cancer 
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